10. Chris Murray, Sr. VP, Technical Operations, Blueprint Medicines

episode

Biotech 2050 Podcast not yet transcribed

▲ 0

Transcript

This episode hasn't been transcribed yet Upvotes decide what gets transcribed next — 0 so far. Sign in to upvote

Related

recent transcribed audio

NPR News: 09-29-2026 7AM EDT 4 min · 29 Sep 2026 · NPR News Now

7AM ET 09/29/2026 Newscast 3 min · 29 Sep 2026 · Fox News Hourly Update

Most replayed moment: The hidden dangers of hearing loss | Prof. Marcelo Rivolta 8 min · 29 Sep 2026 · ZOE Science & Nutrition

Overmedicated To Death: Former FDA Officer on Presley Gerber & The Psychiatric Crisis in America w/ Dr. Mary Talley Bowden, Dr. Josef Witt-Doerring & Ronald Owens Jr. – Ask Dr. Drew – Ep 670 1h 19m · 29 Sep 2026 · Ask Dr. Drew

Federal boost for Navitas 6 min · 29 Sep 2026 · Wall Street Breakfast

SpaceX Starship Finally Reached Orbit & Why Dudes Are Becoming Cat Dads 29 min · 29 Sep 2026 · Morning Brew Daily

Report any issue

Source

Recorded26 Feb 2020

Publisherfeeds.soundcloud.com ↗

Handlerec:2867041

Show notes

Chris is Sr. Vice President, Technical Operations at Blueprint Medicines. He has over 25 years of commercial and clinical manufacturing experience in the biopharmaceutical industry and has been fortunate to help develop and commercialize numerous oncology medicines. He has been in his current role since October 2017.

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.

Sign in